HemosIL ReadiPlasTin (20 mL), Part number 0020301400. An in vitro diagnostic thromboplastin reag...
FDA Device Recall #Z-0276-2022 — Class II — October 13, 2021
Recall Summary
| Recall Number | Z-0276-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 13, 2021 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Instrumentation Laboratory |
| Location | Bedford, MA |
| Product Type | Devices |
| Quantity | 5828 kits (310 US) |
Product Description
HemosIL ReadiPlasTin (20 mL), Part number 0020301400. An in vitro diagnostic thromboplastin reagent.
Reason for Recall
The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or do not pass for each vial of reagent, there is a potential risk of reporting an erroneous result.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AZ, CA, IA, IL, KS, ME, MI, NC, NY, OK, SC, and VA. The countries of Canada, Chile, China, Costa Rica, Italy, Japan, and South Korea. ***Updated 3/3/22*** Expansion includes states of IN, MN, and NC.
Lot / Code Information
Lot N0705526 UDI: 08426950632887 ***Updated 3/3/22*** Firm has expanded recall to include the following lot: N0806224
Other Recalls from Instrumentation Laboratory
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1538-2026 | Class II | GEM Premier 5000; Part No. 00055430008. | Jan 20, 2026 |
| Z-1528-2026 | Class II | GEM Premier 5000 PAK; Part No. 00055407504. | Jan 20, 2026 |
| Z-1524-2026 | Class II | GEM Premier 5000 PAK, Part No. 00055360004. | Jan 20, 2026 |
| Z-1533-2026 | Class II | GEM Premier 5000; Part No. 00055415005. | Jan 20, 2026 |
| Z-1534-2026 | Class II | GEM Premier 5000; Part No. 00055415008. | Jan 20, 2026 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.